There are 1076 resources available
YO35 - Relapsed Mantle Cell Lymphoma with Complete Metabolic Response on Rituximab Gemcitabine-Oxaliplatin. Treatment in a Resource Limited Setting in the Philippines, A Case Report
Presenter: Vincent Tatoy
Session: Poster Display session
Resources:
Abstract
YO36 - Rare case of B-lymphoblastic lymphoma: paraspinal mass presenting with paraplegia
Presenter: Naveen K
Session: Poster Display session
Resources:
Abstract
YO37 - Combining targeted therapy with conventional approach in advanced papillary thyroid cancer (PTC)
Presenter: Priyanka Iyer
Session: Poster Display session
Resources:
Abstract
335MO - Prevalence of low muscle mass/sarcopenia in prostate cancer patients undergoing androgen deprivation therapy and association with muscle strength and physical function
Presenter: Dennis Taaffe
Session: Mini Oral session: Genitourinary tumours
Resources:
Abstract
Desmoid tumours
Presenter: Bernd Kasper
Session: Focus on treatment of specific sarcoma types
Resources:
Slides
Webcast
Multi specific immunotherapeutic engagers
Presenter: Camille Rolin
Session: Session in collaboration with AACR - The expanding portfolio of targeted and cellular therapies in oncology-mechanisms of action and proofs of principle
Resources:
Slides
Webcast
Late effects from cancer treatments
Presenter: Cheung Yin Ting
Session: Cancer survivorship: The end is the start
Resources:
Slides
Webcast
Liposarcoma
Presenter: Herbert Ho Fung Loong
Session: Focus on treatment of specific sarcoma types
Resources:
Slides
Webcast
Biparatopic antibodies targeting FGFR2 for the treatment of cholangiocarcinoma and gastric cancer
Presenter: William Sellers
Session: Session in collaboration with AACR - The expanding portfolio of targeted and cellular therapies in oncology-mechanisms of action and proofs of principle
Resources:
Slides
Webcast
336MO - A phase II single-arm, open-label trial of pamiparib in metastatic castration-resistant prostate cancer (mCRPC) patients with deleterious germline or somatic BRCA1/2 alterations or homologous recombination deficiency (HRD): Interim analysis of efficacy and safety results
Presenter: Diwei Zhao
Session: Mini Oral session: Genitourinary tumours
Resources:
Abstract
Slides
Webcast